FBLG: FibroBiologics, Inc. Stock

by  •  • Comments Off on FBLG: FibroBiologics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 61.40
Enterprise Value ($M) 53.69
Book Value ($M) 2.74
Book Value / Share 0.08
Price / Book 22.43
NCAV ($M) 0.47
NCAV / Share 0.01
Price / NCAV 131.76

Profitability (mra)
Return on Invested Capital (ROIC) -4.14
Return on Assets (ROA) -1.50
Return on Equity (ROE) -14.19

Liquidity (mrq)
Quick Ratio 1.23
Current Ratio 1.23

Balance Sheet (mrq) ($M)
Current Assets 8.20
Assets 10.47
Liabilities 7.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-21 22,517 98,604 22.84
2025-01-17 53,947 159,817 33.76
2025-01-16 24,860 208,365 11.93

(click for more detail)

Similar Companies
ETNB – 89bio, Inc. ETON – Eton Pharmaceuticals, Inc.
FATE – Fate Therapeutics, Inc. FHTX – Foghorn Therapeutics Inc.
FOLD – Amicus Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io